ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,000.00
-0.94%
Dow Jones
40,287.53
-0.93%
Brent Oil
82.305
0.03%
Bitcoin
67,754.68
-0.59%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Regenerx Biopharmaceuticals (RGN)

  7. Regenerx Biopharmaceuticals (RGN) News

RGN

Regenerx Biopharm In (RGN)

Regenerx Biopharmaceuticals
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:RGN
DateTimeSourceHeadlineSymbolCompany
12/22/20109:16AMBusiness WireFirst Patient Screened in Phase 2 Trial with RegeneRx’s RGN-259 for Dry Eye SyndromeAMEX:RGNRegenerx Biopharmaceuticals
12/21/20104:31PMEdgar (US Regulatory)Current report filing (8-K)AMEX:RGNRegenerx Biopharmaceuticals
12/20/201010:00AMBusiness WireRegeneRx’s Scientific Advisory Board Member Receives 2011 Camras AwardAMEX:RGNRegenerx Biopharmaceuticals
12/09/201010:51AMBusiness WireRegeneRx Receives Mexican Patent for the Use of TB4 for Prevention and Treatment of Cardiac DamageAMEX:RGNRegenerx Biopharmaceuticals
12/01/201010:30AMBusiness WireRegeneRx Receives Australian Patent Using TB4 to Protect Against Biological, Chemical and Toxic AgentsAMEX:RGNRegenerx Biopharmaceuticals
11/30/20101:41PMBusiness WireResearchers Identify Potential Thymosin Beta 4 ReceptorAMEX:RGNRegenerx Biopharmaceuticals
11/17/20109:35AMBusiness WireRegeneRx Receives Australian Patent Using Tβ4 for Treatment Of Gastrointestinal DisordersAMEX:RGNRegenerx Biopharmaceuticals
11/16/20102:30PMBusiness WireRegeneRx President and CEO to Present at Maxim Group Growth ConferenceAMEX:RGNRegenerx Biopharmaceuticals
11/12/20106:09AMEdgar (US Regulatory)Quarterly Report (10-Q)AMEX:RGNRegenerx Biopharmaceuticals
11/02/20107:30AMBusiness WireRegeneRx Reports Positive Results of Preclinical Dry Eye StudyAMEX:RGNRegenerx Biopharmaceuticals
11/01/20105:06PMEdgar (US Regulatory)Current report filing (8-K)AMEX:RGNRegenerx Biopharmaceuticals
11/01/20104:30PMBusiness WireRegeneRx Receives Non-compliance Notice from NYSE Amex; Intends to Request HearingAMEX:RGNRegenerx Biopharmaceuticals
11/01/201012:56PMBusiness WireRegeneRx Awarded $733,438 from U.S. Government Under the Patient Protection and Affordable Care ActAMEX:RGNRegenerx Biopharmaceuticals
10/26/201011:07AMBusiness WireRegeneRx Announces Letter to Stockholders Posted on WebsiteAMEX:RGNRegenerx Biopharmaceuticals
09/14/20109:08AMBusiness WireRegeneRx Announces TB4 Stroke Study to be Honored at American Heart Association Scientific SessionsAMEX:RGNRegenerx Biopharmaceuticals
09/07/201010:35AMBusiness WireRegeneRx President and CEO to Speak at Rodman & Renshaw Annual Global Investment ConferenceAMEX:RGNRegenerx Biopharmaceuticals
09/03/20105:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
09/03/20105:22PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:RGNRegenerx Biopharmaceuticals
09/02/20108:44AMEdgar (US Regulatory)Current report filing (8-K)AMEX:RGNRegenerx Biopharmaceuticals
09/02/20107:00AMBusiness WireRegeneRx Appoints R. Don Elsey to Board of DirectorsAMEX:RGNRegenerx Biopharmaceuticals
08/20/20104:01PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:RGNRegenerx Biopharmaceuticals
08/13/20106:02AMEdgar (US Regulatory)Quarterly Report (10-Q)AMEX:RGNRegenerx Biopharmaceuticals
08/02/20108:30AMBusiness WireBritish Researchers Report that TB4 is Essential to Heart DevelopmentAMEX:RGNRegenerx Biopharmaceuticals
07/21/20104:48PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)AMEX:RGNRegenerx Biopharmaceuticals
07/20/20105:26PMEdgar (US Regulatory)Current report filing (8-K)AMEX:RGNRegenerx Biopharmaceuticals
07/19/201012:30PMBusiness WireResearchers Report in Neuroscience that TB4 Improves Neurological Function after StrokeAMEX:RGNRegenerx Biopharmaceuticals
07/16/20105:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
07/16/20105:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
07/16/20105:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
07/16/20105:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
 Showing the most relevant articles for your search:AMEX:RGN

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
HIRU
Hiru (PK)
USOTC
SPZI
Spooz (PK)
USOTC
RONN
Ronn Motor (PK)
COIN
BTCUSD
Bitcoin
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
COOP
Mr Cooper
USOTC
KEGS
1812 Brewing (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
AMRN
Amarin
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
NSAV
Net Savings Link (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved